Patient Centricity
The patients we serve around the world are able to lead better lives. Patients inspire the work we do every day.
Plasma, the liquid part of blood, contains proteins and other components of incalculable therapeutic value. From plasma, Grifols develops medicines to treat patients around the world living with chronic, rare, prevalent and, at times, life-threatening diseases.
The patients we serve around the world are able to lead better lives. Patients inspire the work we do every day.
Our Bioscience division has the largest network of plasma donation centers in the world and markets plasma-derived medicines, as well as other innovative treatments with applications in various fields of medicine.
HEMATOLOGY
HEPATOLOGY / INTENSIVE CARE
IMMUNOLOGY / INFECTIOUS DISEASES
PULMONOLOGY
NEUROLOGY
Grifols' integrated production process guarantees the highest standards of quality and safety, from initial donation to final delivery of medicines to the patient.
Plasma donations undergo a long and complex manufacturing process that ensures the quality and safety of plasma-derived medicines.
Advancing patient care with diagnostic solutions that improve disease detection and management and simplify laboratory operations.
Serving the needs of hospital pharmacies to contribute to safe, high-quality healthcare for patients worldwide.
Supplying high-quality biological materials for life-science research, clinical trials, and for manufacturing pharmaceutical and diagnostic products.